Talat Imran - Net Worth and Insider Trading
Talat Imran Net Worth
The estimated net worth of Talat Imran is at least $648,124 dollars as of 2025-01-16. Talat Imran is the CEO of Rani Therapeutics Holdings Inc and owns about 494,751 shares of Rani Therapeutics Holdings Inc (RANI) stock worth over $648,124. Details can be seen in Talat Imran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Talat Imran has not made any transactions after 2024-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Talat Imran
Talat Imran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Talat Imran owns 1 companies in total, including Rani Therapeutics Holdings Inc (RANI) .
Click here to see the complete history of Talat Imran’s form 4 insider trades.
Insider Ownership Summary of Talat Imran
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RANI | Rani Therapeutics Holdings Inc | 2024-12-09 | director & CEO |
Talat Imran Latest Holdings Summary
Talat Imran currently owns a total of 1 stock. Talat Imran owns 494,751 shares of Rani Therapeutics Holdings Inc (RANI) as of December 9, 2024, with a value of $648,124.
Latest Holdings of Talat Imran
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RANI | Rani Therapeutics Holdings Inc | 2024-12-09 | 494,751 | 1.31 | 648,124 |
Holding Weightings of Talat Imran
Talat Imran Form 4 Trading Tracker
According to the SEC Form 4 filings, Talat Imran has made a total of 5 transactions in Rani Therapeutics Holdings Inc (RANI) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Rani Therapeutics Holdings Inc is the acquisition of 10,296 shares on December 9, 2024, which cost Talat Imran around $19,974.
Insider Trading History of Talat Imran
- 1
Talat Imran Trading Performance
GuruFocus tracks the stock performance after each of Talat Imran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Talat Imran is 69.27%. GuruFocus also compares Talat Imran's trading performance to market benchmark return within the same time period. The performance of stocks bought by Talat Imran within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Talat Imran's insider trading performs compared to the benchmark.
Performance of Talat Imran
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.98 | | | | | |
| Relative Return to S&P 500(%) | 20.35 | | | | | |
Talat Imran Ownership Network
Ownership Network List of Talat Imran
Ownership Network Relation of Talat Imran
Talat Imran Owned Company Details
What does Rani Therapeutics Holdings Inc do?
Who are the key executives at Rani Therapeutics Holdings Inc?
Talat Imran is the director & CEO of Rani Therapeutics Holdings Inc. Other key executives at Rani Therapeutics Holdings Inc include CHIEF BUSINESS OFFICER Kate Mckinley , 10 percent owner South Cone Investments Limited Partnership , and 10 percent owner Quiroga Cortes Isidoro Alfonso .
Rani Therapeutics Holdings Inc (RANI) Insider Trades Summary
Over the past 18 months, Talat Imran made 5 insider transaction in Rani Therapeutics Holdings Inc (RANI) with a net purchase of 50,296. Other recent insider transactions involving Rani Therapeutics Holdings Inc (RANI) include a net purchase of 1,435,805 shares made by South Cone Investments Limited Partnership , a net sale of 5,265,165 shares made by Quiroga Cortes Isidoro Alfonso , and a net purchase of 50,500 shares made by Jean Luc Butel .
In summary, during the past 3 months, insiders sold 0 shares of Rani Therapeutics Holdings Inc (RANI) in total and bought 28,256 shares, with a net purchase of 28,256 shares. During the past 18 months, 9,094,525 shares of Rani Therapeutics Holdings Inc (RANI) were sold and 5,384,421 shares were bought by its insiders, resulting in a net sale of 3,710,104 shares.
Rani Therapeutics Holdings Inc (RANI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rani Therapeutics Holdings Inc Insider Transactions
Talat Imran Mailing Address
Above is the net worth, insider trading, and ownership report for Talat Imran. You might contact Talat Imran via mailing address: C/o Rani Therapeutics Holdings, Inc., 2051 Ringwood Avenue, San Jose Ca 95131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
